HCW Biologics completes $4.0M warrant inducement; lowers exercise price to $2.66

HCW Biologics Inc.

Inducement agreement lowers exercise price on 1.51M existing warrants from $7.45 to $2.66 per share.
Gross proceeds of approximately $4.0M from immediate exercise of November 2024 and May 2025 warrants.
Issues new warrants to purchase up to 3,020,410 shares at $2.41, exercisable for 5.5 years from Nov 20, 2025.
Maxim Group LLC acted as financial advisor; company to file resale registration statement within 30 days.
Dilution to existing shareholders: warrants exercisable for 3.02M new shares; HCWB stock symbol unchanged.

item 1.01item 3.02item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.